Why the study?
This study aimed to create machine learning models for predicting early neurological deterioration and risk classification in acute ischemic stroke before intravenous thrombolysis.
Can machine learning models combining clinical indicators and inflammatory cell ratios accurately predict early neurological deterioration in acute ischemic stroke patients before intravenous thrombolysis?
Can machine learning models combining clinical indicators and inflammatory cell ratios accurately predict early neurological deterioration in acute ischemic stroke patients before intravenous thrombolysis?
Machine learning models incorporating clinical indicators and inflammatory cell ratios can accurately predict early neurological deterioration in acute ischemic stroke patients prior to intravenous thrombolysis.
Answers are grounded in this paper and cite their sources.
May aid pre-thrombolysis risk stratification in acute ischemic stroke; leaves open prospective validation before clinical use.
This study aimed to create machine learning models for predicting early neurological deterioration and risk classification in acute ischemic stroke (AIS) before intravenous thrombolysis (IVT). The study included 704 AIS patients categorized into END and non-END groups. The least absolute shrinkage and selection operator (LASSO) regression was employed to select the best predictors from clinical indicators, leading to the creation of Model 1. Univariate and multivariate logistic regression analyses identified independent predictive factors for END from inflammatory cell ratios. These factors were combined with clinical indicators, forming Model 2. Receiver operating characteristic (ROC) curves assessed the models' predictive performance. Key variables for Model 1 included the NIHSS score, systolic blood pressure, and lymphocyte percentage. Neutrophil-to-Lymphocyte ratio, Platelet-to-Neutrophil ratio, and Platelet-to-Lymphocyte ratio independently predicted END. Model 1 exhibited moderate predictive ability (AUC 0.721 in training, AUC 0.635 in test). Model 2, which integrated clinical indicators and inflammatory cell ratios, demonstrated strong performance in both training (AUC 0.862) and test (AUC 0.816). Machine learning models, combining clinical indicators and inflammatory cell ratios before IVT, accurately predict END and associated risk in AIS.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: